Foamix Pharmaceuticals Ltd. (FOMX) Stock: Great Point Partners Boosts its Stake to 7.57%

Page 6 of 10

Page 6 of 10 – SEC Filing
CUSIP
No. M46135105
13G Page
6 of 9 Pages
(g) o A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
(h) o A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
(i) o A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company
Act of 1940 (15 U.S.C. 80a-3).
(j) o Group, in accordance with §240.13d-1(b)(1)(ii)(J).
Item 4. Ownership
Biomedical Value Fund, L.P. (“BVF”) is the record owner of 727,127 shares of Common Stock (the “BVF Shares”).  Great Point Partners, LLC (“Great Point”) is the investment manager of BVF, and by virtue of such status may be deemed to be the beneficial owner of the BVF Shares.  Each of Dr. Jeffrey R. Jay, M.D. (“Dr. Jay”), as senior managing member of Great Point, and Mr. David Kroin (“Mr. Kroin”), as special managing member of Great Point, has voting and investment power with respect to the BVF Shares, and therefore may be deemed to be the beneficial owner of the BVF Shares.  
Biomedical Offshore Value Fund, Ltd. (“BOVF”) is the record owner of 1,047,995 shares of Common Stock (the “BOVF Shares”). Great Point is the investment manager of BOVF, and by virtue of such status may be deemed to be the beneficial owner of the BOVF Shares.  Each of Dr. Jay, as senior managing member of Great Point, and Mr. Kroin, as special managing member of Great Point, has voting and investment power with respect to the BOVF Shares, and therefore may be deemed to be the beneficial owner of the BOVF Shares.  
GEF-SMA, LP (“GEF-SMA”) is the record owner of 812,519 shares of Common Stock (the “GEF-SMA Shares”).  Great Point is the investment manager of GEF-SMA, and by virtue of such status may be deemed to be the beneficial owner of the GEF-SMA Shares.  Each of Dr. Jay, as senior managing member of Great Point, and Mr. Kroin, as special managing member of Great Point, has voting and investment power with respect to the GEF-SMA Shares, and therefore may be deemed to be the beneficial owner of the GEF-SMA Shares.  
Class D Series of GEF-PS, L.P. (“GEF-PS”) is the record owner of 181,784 shares of Common Stock (the “GEF-PS Shares”).  Great Point is the investment manager of GEF-PS and by virtue of such status may be deemed to be the beneficial owner of the GEF-PS Shares.  Each of Dr. Jay, as senior managing member of Great Point, and Mr. Kroin, as special managing member of Great Point, has voting and investment power with respect to the GEF-PS Shares, and therefore may be deemed to be the beneficial owner of the GEF-PS Shares.
Notwithstanding the above, Great Point, Dr. Jay and Mr. Kroin disclaim beneficial ownership of the BVF Shares, the BOVF Shares, the GEF-SMA Shares and the GEF-PS Shares described above, except to the extent of their respective pecuniary interests.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
1. Great Point Partners, LLC
(a) Amount beneficially owned:  2,769,425
(b) Percent of class:  7.57%1
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:   0

Follow Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)

Page 6 of 10